Analystreport

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is now covered by analysts at JMP Securities. They set an "outperform" rating and a $64.00 price target on the stock.

Rhythm Pharmaceuticals, Inc.  (RYTM) 
Last rhythm pharmaceuticals, inc. earnings: 3/8 08:12 am Check Earnings Report
US:NASDAQ Investor Relations: ir.rhythmtx.com